Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BOTULINUM TOXIN TYPE A Cause Urinary incontinence? 11 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Urinary incontinence have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 0.3% of all adverse event reports for BOTULINUM TOXIN TYPE A.

11
Reports of Urinary incontinence with BOTULINUM TOXIN TYPE A
0.3%
of all BOTULINUM TOXIN TYPE A reports
0
Deaths
6
Hospitalizations

How Dangerous Is Urinary incontinence From BOTULINUM TOXIN TYPE A?

Of the 11 reports, 6 (54.5%) required hospitalization, and 2 (18.2%) were considered life-threatening.

Is Urinary incontinence Listed in the Official Label?

Yes, Urinary incontinence is listed as a known adverse reaction in the official FDA drug label for BOTULINUM TOXIN TYPE A.

What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?

Off label use (1,785) Drug ineffective (1,175) Drug intolerance (1,004) Product use in unapproved indication (950) Headache (797) Migraine (775) Maternal exposure during pregnancy (716) Pain (714) Hypoaesthesia (703) Nausea (665)

What Other Drugs Cause Urinary incontinence?

MIRABEGRON (611) ADALIMUMAB (471) FINGOLIMOD (470) OCRELIZUMAB (431) RISPERIDONE (406) TERIFLUNOMIDE (365) DIMETHYL (355) ARIPIPRAZOLE (350) DALFAMPRIDINE (344) QUETIAPINE (336)

Which BOTULINUM TOXIN TYPE A Alternatives Have Lower Urinary incontinence Risk?

BOTULINUM TOXIN TYPE A vs BREMELANOTIDE BOTULINUM TOXIN TYPE A vs BRENTUXIMAB BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN BOTULINUM TOXIN TYPE A vs BREO ELLIPTA BOTULINUM TOXIN TYPE A vs BREXANOLONE

Related Pages

BOTULINUM TOXIN TYPE A Full Profile All Urinary incontinence Reports All Drugs Causing Urinary incontinence BOTULINUM TOXIN TYPE A Demographics